Skip to content

Appropriateness of Intravenous Antibiotics Prescriptions at Hospital Discharge

Quasi-experimental Study Comparing Intravenous Antibiotics Prescriptions at Hospital Discharge With and Without ID Consultation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03173768
Enrollment
173
Registered
2017-06-02
Start date
2015-11-01
Completion date
2017-02-28
Last updated
2017-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anti-Infectives Adverse Reaction

Keywords

intravenous antibiotics, appropriateness, outpatient antimicrobial therapy

Brief summary

A quasi-experimental study was conducted among patients receiving care at the medicine units of the Maharaj Nakorn Chiang Mai Hospital to determine the appropriateness of intravenous antibiotics at hospital discharge with and without ID consultation.

Detailed description

The pre-intervention period was started from November 1, 2015 to April 30, 2016 (6-month period), in which the intravenous antibiotics at hospital discharge were prescribed by the primary care team. The post-intervention period was started from May 1, 2016 to February 28, 2017 (10-month period), in which the intravenous antibiotics at hospital discharge were reviewed and intervened by ID team. The appropriateness of intravenous antibiotics was assessed separately by the ID fellow and ID specialist. If disagreement occurred, the feedback to the ID fellow was performed and the decision by ID specialist was used in the final analysis of appropriateness. In post-intervention period, ID fellow modified the intravenous antibiotics ordered by the primary team if those intravenous antibiotics were judged as inappropriate by ID fellow as follows: 1) discontinue intravenous antibiotics (treatment was complete), 2) switch to oral antibiotics, 3) change intravenous antibiotics to cover isolated pathogens, 4) adjust the dose of intravenous antibiotics, and 5) change the duration of intravenous antibiotics Finally, ID specialist retrospectively assessed the appropriateness of intravenous antibiotics at hospital discharge managed by ID fellow in post-intervention period.

Interventions

PROCEDUREID specialist approval

Appropriateness of intravenous antibiotics ordered by the primary team was assessed by ID specialist. ID fellow modified the intravenous antibiotics ordered by the primary team if those intravenous antibiotics were judged as inappropriate by ID fellow as follows: 1) discontinue intravenous antibiotics (treatment was complete), 2) switch to oral antibiotics, 3) change intravenous antibiotics to cover isolated pathogens, 4) adjust the dose of intravenous antibiotics, and 5) change the duration of intravenous antibiotics. Finally, ID specialist retrospectively assessed the appropriateness of intravenous antibiotics at hospital discharge managed by ID fellow in post-intervention period.

Sponsors

Chiang Mai University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No

Inclusion criteria

All adult patients who met the following criteria were consecutively enrolled; 1. age≥ 15 years old and 2. had infections at any sites and received intravenous antibiotics.

Exclusion criteria

\- They were evaluated by infectious diseases specialist for appropriate antibiotics during admission

Design outcomes

Primary

MeasureTime frameDescription
The proportion of appropriateness of intravenous antibiotics prescriptions at hospital discharge between groups16 monthsTo calculate the number of antibiotic prescriptions at hospital discharge over the total number of prescriptions, comparing between pre-and post-intervention period.

Secondary

MeasureTime frameDescription
The costs of antibiotics for the course of treatment16 monthsTo compare the cost of antibiotics for the course of treatment between the 2 periods
Clinical improvement at 1 week1 weekTo calculate the number of patients who had clinical improvement at 1 week over the total number of patients in each period, comparing between the 2 periods
Readmission within 30 days, length of hospital stay30 daysTo calculate the number of patients who were readmitted within 30 days over the total number of patients in each period, comparing between the 2 periods
Length of hospital stay60 daysTo calculate the length of hospital stays in days between 2 periods

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026